Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG43126

CCDC91 Knockout NCI-H1975 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Lung

  • Disease:

    Carcinoma

The CCDC91 Knockout NCI-H1975 Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout population of CCDC91 in the EGFR-mutant NCI-H1975 lung adenocarcinoma line. CCDC91 encodes a centriolar satellite protein that organizes microtubules and promotes ciliogenesis, interacting with PCM1 and CEP290. Its loss disrupts primary cilium formation and attenuates Hedgehog and Wnt signaling, downregulating targets like GLI1 and MYC. This model enables investigation of cilia-dependent signaling in EGFR-driven NSCLC, drug resistance mechanisms, and tumor cell behavior. Applications include ciliogenesis assays, immunofluorescence, Western blotting, and functional migration/viability studies. For technical inquiries, please contact Ascent Research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    NCI-H1975

    Sex of Donor

    Female

    Gene Name

    CCDC91

    Gene Identifier

    NCBI Gene ID 55297

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CCDC91 Knockout NCI-H1975 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population with disruption of the CCDC91 gene in NCI-H1975 lung adenocarcinoma cells. This loss-of-function model facilitates investigation of CCDC91 roles in centriolar satellite biology, primary cilium assembly, and related signaling. The polyclonal format provides a heterogeneous pool of edited cells, avoiding clonal selection biases.

NCI-H1975 is an adherent epithelial line from pleural effusion of a 63-year-old female with non-small cell lung adenocarcinoma. It harbors EGFR L858R and T790M mutations, representing a key model of acquired resistance to EGFR tyrosine kinase inhibitors. The aneuploid line captures tumor heterogeneity and is widely employed to study drug resistance mechanisms, oncogenic signaling, and epithelial-mesenchymal transition in NSCLC.

CCDC91 encodes a centriolar satellite protein localizing to pericentriolar matrix, essential for primary cilium formation through regulation of microtubule organization and satellite integrity. It interacts with satellite components PCM1, CEP290, CEP131, SSX2IP, and OFD1, and recruits ciliary assembly factors like IFT88, BBS4, and ARL13B. Functioning downstream of the CP110-CEP97 complex and RFX transcription factors, CCDC91 is upstream of ciliogenesis-dependent Hedgehog and Wnt signaling. Its disruption attenuates Hedgehog pathway activation (reducing SMO, SUFU, and GLI1/3) and diminishes Wnt/??-catenin signaling (affecting AXIN2, DVL, and ??-catenin stability), leading to downregulation of downstream effectors MYC and Cyclin D1.

In NCI-H1975 cells driven by mutant EGFR, loss of CCDC91 and impaired ciliogenesis offer a system to probe interplay between EGFR, Hedgehog, and Wnt pathways. Because primary cilia can modulate receptor tyrosine kinase signaling and cell cycle entry, CCDC91 knockout may reveal vulnerabilities in EGFR-mutant NSCLC, especially under therapeutic pressure. This model enables dissection of how centriolar satellite dysfunction influences tumor cell proliferation, migration, and survival, and may uncover synthetic lethal interactions or targets for overcoming resistance.

These polyclonal knockout cells suit serum starvation-induced ciliogenesis assays, immunofluorescence for acetylated ??-tubulin/ARL13B, Western blotting for GLI proteins and EGFR signaling, and RT-qPCR for ciliary genes. Functional analyses include scratch wound migration, MTT viability, and co-immunoprecipitation of satellite complexes. They also allow assessment of Hedgehog/Wnt pathway responses during EGFR inhibitor treatment. For further details, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)